Development of an intein-mediated split-Cas9 system for gene therapy - Test2 - elhamkhani - TriplyDB

Development of an intein-mediated split-Cas9 system for gene therapy

Development of an intein-mediated split-Cas9 system for gene therapy

http://www.wikidata.org/entity/Q34481059

about

Genome Engineering with TALE and CRISPR Systems in Neuroscience CRISPR/Cas9 and cancer targets: future possibilities and present challenges Resources for the design of CRISPR gene editing experiments Application of CRISPR/Cas9 Technology to HBV A new age in functional genomics using CRISPR/Cas9 in arrayed library screening Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase CRISPR/Cas9: Transcending the Reality of Genome Editing.Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing A Split Staphylococcus aureus Cas9 as a Compact Genome-Editing Tool in Plants.Genetic and epigenetic control of gene expression by CRISPR-Cas systems.In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch Reconfigurable hybrid interface for molecular marker diagnostics and in-situ reporting Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.Gene Editing for Treatment of Neurological Infections.Integration and exchange of split dCas9 domains for transcriptional controls in mammalian cells.A multifunctional AAV-CRISPR-Cas9 and its host response.Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools.Therapeutic genome engineering via CRISPR-Cas systems.CRISPR-Cas9 technology: applications and human disease modelling.CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.Genome Editing for the Study of Cardiovascular Diseases.Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.Emerging Gene Therapies for Genetic Hearing Loss.Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting.Inducible CRISPR genome-editing tool: classifications and future trends.Synthetic Gene Expression Circuits for Designing Precision Tools in Oncology.Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering.A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.Synthetic Gene Expression Circuits for Designing Precision Tools in Oncology.Genetically engineered pigs as models for human disease.Oligonucleotide conjugated multi-functional adeno-associated viruses.Genome Surgery and Gene Therapy in Retinal Disorders.In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.Delivering CRISPR: a review of the challenges and approaches Protein Engineering Strategies to Expand CRISPR-Cas9 Applications

P2860

Q26752488-408D485E-BEF7-4D80-B87E-27426544E174 Q26769907-2FBFED7D-6EB3-4BB6-AF67-D130AFF810B1 Q26776435-DA1E9492-D9C7-475B-9A28-7B9F00FDA09D Q26779150-AA3BAF58-347D-4790-9BE9-4A44BB9A2B7C Q26781135-9F407A18-1D6E-4A0B-B29B-D64D45C90597 Q28831343-DCCC960E-E8D0-42B3-911E-E31AEF1E309C Q29114083-CC60416C-3FE5-4EEC-B9E1-550298E17B43 Q33632925-C7281724-CC4B-4825-B66A-68E739A080D6 Q33655722-216F2DC2-D6A7-403F-B21E-68CC5467663D Q33727679-E086C35D-BF51-46B5-BFA2-B2EE5C5E77D2 Q33777855-91927825-7706-44A1-831B-932193817983 Q33807299-B3BDB77C-9493-472B-B1BD-EAB44863311F Q34524602-55E5C0BC-5133-4E9C-A12A-50B64587A9B5 Q35995485-A8ADCA70-8411-420A-A857-3B97BFE91368 Q36675277-E41EDF52-E494-49BB-9FC4-8264C895FF4D Q37136471-FABCB39B-D94C-490C-9B06-27D744CD312E Q37338843-CC0BD263-A5C5-4E8B-A816-12CC04185678 Q37731772-97BB2590-E43D-4A51-9B4F-C11A3CAE0510 Q38682882-4A32E2E3-7108-4B55-88A3-A2B34DADA829 Q38716317-303F49C6-1122-46C0-8C2E-2521A52D5DF0 Q38757432-45CCF122-B0DF-42F3-9641-630FB857F3AB Q38848400-673F8842-0D7A-4A50-9B58-5B2CAC6A59A9 Q39014648-601D446B-E4F9-496E-AE75-EE42BAF459A7 Q39144904-F691E790-FCFF-4254-9104-32FBEEB0A785 Q39319380-C413B1C3-CB1B-4B33-A4ED-F506D2AA47B5 Q40080564-89A5E40F-98B7-4BD6-A048-17B3A94A1E57 Q41699665-E32F53CE-B725-41DD-B01D-94EA1C9A434E Q46302920-BBAAB8E4-18DE-4750-9108-B54A3A4A5A8E Q46554724-082D6F26-20C4-4F18-899D-72B82A561E78 Q47162699-F2A8FE8E-9293-47FA-B32E-F4763CD74F1A Q47356373-D9E02273-F155-4A54-BC79-2F4D5C297CD3 Q47559748-53595696-10FD-4DF0-A4D3-A6444DAAB26E Q47686884-CC991A66-BB8E-4181-B695-23C63F25AD62 Q50107614-A86719F6-1AC1-479D-B165-726BC2FFDBFE Q50333514-43D6D36F-C79A-4D1B-BBD5-F97BBA704392 Q52429662-9E1A0B67-2454-49F9-B7F6-F836E32D713C Q54213414-0B2073FE-A5ED-4CD9-8C1B-C2123FB36B5C Q55546604-8E0714F8-D8DB-48BF-B938-7B7C51B3151A Q56610090-6428DCE1-DBC3-4949-B10A-DFAE96190516 Q56889180-9DEF6641-3D6E-4028-983C-C5EC8543F322

P2860

Development of an intein-mediated split-Cas9 system for gene therapy

http://www.wikidata.org/entity/Q34481059

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Development of an intein-mediated split-Cas9 system for gene therapy

@ast

Development of an intein-mediated split-Cas9 system for gene therapy

@en

Development of an intein-mediated split-Cas9 system for gene therapy

@nl

type

label

Development of an intein-mediated split-Cas9 system for gene therapy

@ast

Development of an intein-mediated split-Cas9 system for gene therapy

@en

Development of an intein-mediated split-Cas9 system for gene therapy

@nl

prefLabel

Development of an intein-mediated split-Cas9 system for gene therapy

@ast

Development of an intein-mediated split-Cas9 system for gene therapy

@en

Development of an intein-mediated split-Cas9 system for gene therapy

@nl

P1433

Q34481059-C3FC9B75-EB26-46A4-96E5-580890EF8700

P1476

Q34481059-19AE97DE-B7B2-4FAF-85A9-AE35FEA362AF

P2093

Q34481059-10AB7BB2-F37E-4192-A35E-3A7DFCE04FA3

Q34481059-761A4F4D-868F-4940-990B-1DB92D8ED26B

Q34481059-B31B899A-8346-4CBD-917B-11F5080D11C4

Q34481059-D08B38E2-491B-48B9-96AF-E1EB17AE645E

Q34481059-FC66F1B9-E3E3-4C17-9BFD-FE60AFDC1BED

P2860

Q34481059-0363793E-C53F-473C-837E-F090731665FB

Q34481059-037B7EB5-03B4-40E2-BCBD-FFD72E730F8D

Q34481059-05B8DCB4-0111-4348-8C21-7BCA37DB4A64

Q34481059-097AF5E6-8C7E-426B-83F8-A85A06C2FE9B

Q34481059-0E1B4019-82A7-4DEC-A0AA-962139442BEB

Q34481059-0F56184D-6C50-4004-9094-B30FF8BBAE54

Q34481059-18E3E93C-BB04-4111-B767-51F35B3DB6AA

Q34481059-23019865-B7A9-4ADE-A7B2-83E6495750D6

Q34481059-26519FE2-FEB5-44FE-983A-3E78D1D4C1D5

Q34481059-27B87A73-F229-4AC9-80A7-B7ACD44D0D2D

P304

Q34481059-03740D43-816F-4259-8304-131EF909DE78

P31

Q34481059-0EA88508-6935-4445-B2B3-EDB9808A4D7B

P356

Q34481059-052F8A3B-7FB5-4F31-A162-56B580DABE6A

P407

Q34481059-0A4F8175-B556-48AD-BB32-74191A610411

P433

Q34481059-4D9FB015-E331-411B-AAF8-0FDD45184C54

P478

Q34481059-7476D04C-898D-47C3-991D-6A2FD9E3E87D

P50

Q34481059-98C47C58-7376-4746-B29E-B2136491739F

Q34481059-E034D9C1-A51D-4073-81E8-1D65EB447305

P577

Q34481059-268198D0-06E9-4F5F-A0DD-A579E94A870A

P5875

Q34481059-F31DC193-149E-4469-8A2D-ACC8D506746A

P698

Q34481059-EA2922AC-D0A2-4A55-8B84-FDE978E47468

P921

Q34481059-581C14E4-85B3-4523-AA9D-69F2DFF83251

P932

Q34481059-35D0C139-B244-4EEB-A0D0-3C9BE3721FF1

P356

P1433

Nucleic Acids Research

P1476

Development of an intein-mediated split-Cas9 system for gene therapy

@en

P2093

Dong-Jiunn Jeffery Truong

http://www.w3.org/2001/XMLSchema#string

Karin Kühner

http://www.w3.org/2001/XMLSchema#string

Oskar Ortiz

http://www.w3.org/2001/XMLSchema#string

Stanislas Werfel

http://www.w3.org/2001/XMLSchema#string

Wolfgang Wurst

http://www.w3.org/2001/XMLSchema#string

P2860

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation

Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA

Theory for the folding and stability of globular proteins

Optical control of mammalian endogenous transcription and epigenetic states

Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation.

Adenoviral vector immunity: its implications and circumvention strategies.

Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions.

Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.

P304

6450-6458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKV601

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Engelhardt

P577

2015-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278793522

http://www.w3.org/2001/XMLSchema#string

P698

26082496

http://www.w3.org/2001/XMLSchema#string

P921

P932

4513872

http://www.w3.org/2001/XMLSchema#string